Literature DB >> 26680947

Second-Line Chemotherapy for Advanced Non-small Cell Lung Cancer: Past, Present, and Hope for the Future.

Keunchil Park.   

Abstract

Entities:  

Year:  2003        PMID： 26680947     DOI： 10.4143/crt.2003.35.4.279

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN： 1598-2998            Impact factor:   4.679


× No keyword cloud information.
  1 in total

1.  Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer.

Authors:  Xin Wang; Jun Zhao; Lu Yang; Li Mao; Tongtong An; Hua Bai; Shuhang Wang; Xuyi Liu; Guoshuang Feng; Jie Wang
Journal:  Med Oncol       Date:  2009-06-02       Impact factor: 3.064
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.